ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife
AngioDynamics' latest regulatory approval is likely to pave the way for an alternative to conventional radical surgery and improve patient outcomes.
FierceBiotech3d
FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer
AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system, designed to precisely target ...
AngioDynamics Receives FDA Clearance for NanoKnife System, Poised for Growth with New Market Opportunities and Clinical Success
Canaccord Genuity analyst John Young CFA has maintained their bullish stance on ANGO stock, giving a Buy rating today.Pick the best stocks and ...
MassDevice4d
AngioDynamics wins FDA clearance for NanoKnife system in prostate tissue ablation
AngioDynamics received FDA 510(k) clearance for its NanoKnife system for prostate tissue ablation in intermediate-risk ...
NanoKnife gains FDA clearance for prostate tissue ablation
AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer ...
AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife
Shares of AngioDynamics hit a 52-week high after the company's NanoKnife System for prostate tissue ablation received regulatory clearance. The stock jumped almost 35% to a high of $9.42 in early ...
AngioDynamics receives FDA 510(k) clearance for NanoKnife System
AngioDynamics (ANGO) announced it received U.S. FDA 510(k) clearance for the NanoKnife System for prostate tissue ablation. Pick the best ...